Skip to main content

Table 3 Tumor histopathology with the demonstration of the number (No.) and percentage (%) for each type

From: Role of fused PET/CT compared to the standard contrast-enhanced CT in the follow-up assessment of the treated gastric malignancy

Histopathology typeNo. of patients% of patients
Adenocarcinoma50 patients73.5%
Lymphoma16 patients23.5%
Carcinoid2 patients3%